Cutia Therapeutics (2487.HK)
Cutia Therapeutics an investment holding company, engages in the research, development, manufacture, and commercialization of scalp diseases and care products, and skin care products in the People's Republic of China and Hong Kong.
2.34-0.03%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-72.5%
The outlook
Cutia Therapeutics currently reads as leaning bearish based on below its 50- & 200-day averages, 2% of the way from its 52-week low to high, avg target +386% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range2% of the way from its 52-week low to high
Price targetAvg target +386% vs current price
Analyst price target
~12-month · 2 analysts11.38average target+386.2% vs now
Now 2.34
Low 7.63High 15.12
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$850.3M
52-wk high
12.00
52-wk low
2.14
50-day avg
3.05
200-day avg
4.80
Trailing P/E
—